Aclaris Therapeutics Stock Forward View - Accumulation Distribution
| ACRS Stock | USD 3.51 0.08 2.33% |
Aclaris Stock outlook is based on your current time horizon.
At this time, The relative strength index (RSI) of Aclaris Therapeutics' share price is at 54. This suggests that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Aclaris Therapeutics, making its price go up or down. Momentum 54
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.15) | EPS Estimate Current Year (0.50) | EPS Estimate Next Year (0.57) | Wall Street Target Price 7.6667 | EPS Estimate Current Quarter (0.14) |
Using Aclaris Therapeutics hype-based prediction, you can estimate the value of Aclaris Therapeutics from the perspective of Aclaris Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Aclaris Therapeutics using Aclaris Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Aclaris using crowd psychology based on the activity and movement of Aclaris Therapeutics' stock price.
Aclaris Therapeutics Short Interest
An investor who is long Aclaris Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Aclaris Therapeutics and may potentially protect profits, hedge Aclaris Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 2.0369 | Short Percent 0.0567 | Short Ratio 5.06 | Shares Short Prior Month 4.3 M | 50 Day MA 3.0516 |
Aclaris Relative Strength Index
Aclaris Therapeutics Hype to Price Pattern
Investor biases related to Aclaris Therapeutics' public news can be used to forecast risks associated with an investment in Aclaris. The trend in average sentiment can be used to explain how an investor holding Aclaris can time the market purely based on public headlines and social activities around Aclaris Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Aclaris Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Aclaris Therapeutics.
Aclaris Therapeutics Implied Volatility | 2.44 |
Aclaris Therapeutics' implied volatility exposes the market's sentiment of Aclaris Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Aclaris Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Aclaris Therapeutics stock will not fluctuate a lot when Aclaris Therapeutics' options are near their expiration.
Aclaris Therapeutics after-hype prediction price | USD 3.52 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Aclaris Therapeutics to cross-verify your projections. Prediction based on Rule 16 of the current Aclaris contract
Based on the Rule 16, the options market is currently suggesting that Aclaris Therapeutics will have an average daily up or down price movement of about 0.15% per day over the life of the 2026-03-20 option contract. With Aclaris Therapeutics trading at USD 3.51, that is roughly USD 0.005353 . If you think that the market is fully incorporating Aclaris Therapeutics' daily price movement you should consider acquiring Aclaris Therapeutics options at the current volatility level of 2.44%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-03-20 Aclaris Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Aclaris Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Aclaris Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Aclaris Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Aclaris Therapeutics' open interest, investors have to compare it to Aclaris Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Aclaris Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Aclaris. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Aclaris Therapeutics Additional Predictive Modules
Most predictive techniques to examine Aclaris price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Aclaris using various technical indicators. When you analyze Aclaris charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 44072.06 | 96396.72 |
| Check Aclaris Therapeutics Volatility | Backtest Aclaris Therapeutics | Information Ratio |
Aclaris Therapeutics Trading Date Momentum
| On January 30 2026 Aclaris Therapeutics was traded for 3.51 at the closing time. The top price for the day was 3.80 and the lowest listed price was 3.48 . The trading volume for the day was 1.1 M. The trading history from January 30, 2026 did not affect price variability. The overall trading delta against the current closing price is 1.14% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Aclaris Therapeutics to competition |
Other Forecasting Options for Aclaris Therapeutics
For every potential investor in Aclaris, whether a beginner or expert, Aclaris Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Aclaris Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Aclaris. Basic forecasting techniques help filter out the noise by identifying Aclaris Therapeutics' price trends.Aclaris Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aclaris Therapeutics stock to make a market-neutral strategy. Peer analysis of Aclaris Therapeutics could also be used in its relative valuation, which is a method of valuing Aclaris Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Aclaris Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Aclaris Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aclaris Therapeutics shares will generate the highest return on investment. By undertsting and applying Aclaris Therapeutics stock market strength indicators, traders can identify Aclaris Therapeutics entry and exit signals to maximize returns.
Aclaris Therapeutics Risk Indicators
The analysis of Aclaris Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Aclaris Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting aclaris stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.68 | |||
| Semi Deviation | 4.57 | |||
| Standard Deviation | 9.78 | |||
| Variance | 95.57 | |||
| Downside Variance | 25.61 | |||
| Semi Variance | 20.86 | |||
| Expected Short fall | (5.87) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Aclaris Therapeutics
The number of cover stories for Aclaris Therapeutics depends on current market conditions and Aclaris Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Aclaris Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Aclaris Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Aclaris Therapeutics Short Properties
Aclaris Therapeutics' future price predictability will typically decrease when Aclaris Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Aclaris Therapeutics often depends not only on the future outlook of the potential Aclaris Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aclaris Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 77.3 M | |
| Cash And Short Term Investments | 113.6 M |
Additional Tools for Aclaris Stock Analysis
When running Aclaris Therapeutics' price analysis, check to measure Aclaris Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aclaris Therapeutics is operating at the current time. Most of Aclaris Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aclaris Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aclaris Therapeutics' price. Additionally, you may evaluate how the addition of Aclaris Therapeutics to your portfolios can decrease your overall portfolio volatility.